Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 7Heart Failure 2Solid Tumors 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Pediatric Brain Tumor 1Lung Neoplasms 1Inflammation 1Hyperinsulinism 1Adenocarcinoma of Lung 1

Interventions

Pemetrexed 6pembrolizumab 5Magnetic Resonance Spectroscopy 5Carboplatin 5Specimen Handling 4Mastectomy, Segmental 4Cisplatin 4Bevacizumab 4durvalumab 2Platinum 2Biopsy 2tislelizumab 1osimertinib 1methyl-4-fluoro-4-deoxyglucose 1methoxyamine 1fludarabine phosphate 1devimistat 1dehydroftorafur 1defactinib 1dapagliflozin 1capmatinib 1aflutinib 1Standard of Care 1Smoking Devices 1Radiotherapy 1Radiation 1RO5126766 1Practice Guidelines as Topic 1Observation 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Adenocarcinoma of Lung × dapagliflozin × Clear all
NCT07235280 2026-02-19

Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocarcinoma

Jonsson Comprehensive Cancer Center

Phase EARLY_PHASE1 Recruiting
48 enrolled
Thoracic

Adenocarcinoma of Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡